The telestroke market helps in the remote diagnosis and treatment of stroke patients. Telestroke technology allows healthcare professionals to assess and consult with stroke patients in real-time, regardless of their geographical location. Through videoconferencing and advanced imaging tools, neurologists can remotely evaluate symptoms, review medical imaging, and recommend timely interventions, such as administering clot-dissolving medications or transferring the patient to a specialized stroke center. This application significantly enhances the speed and efficiency of stroke care, leading to quicker interventions and improved outcomes for patients, particularly in regions with limited access to specialized stroke expertise.
According to Data Bridge Market Research analyzes the U.S. Telestroke Market which was USD 1,546.79 million in 2023, is expected to reach USD 4,672.23 million by 2031, and is expected to undergo a CAGR of 19.1% during the forecast period of 2024 to 2031.
"Growing Integration with Healthcare Systems Boosts the Market Growth"
Seamlessly connecting telestroke solutions with existing healthcare infrastructures, such as electronic health records and diagnostic tools, medical professionals can rapidly assess and treat stroke patients remotely. This integration enhances communication, accelerates decision-making, and ensures efficient coordination between remote specialists and on-site healthcare teams, ultimately leading to improved patient outcomes and increased accessibility to specialized stroke care on a global scale.
What restraints the growth of U.S. telestroke market?
“Lack of Skilled Professionals”
The successful implementation of telestroke services requires specialized medical expertise in neurology and stroke care. The shortage of qualified professionals capable of delivering timely and accurate telemedical assessments hinders the widespread adoption of telestroke solutions. This limitation undermines the potential reach and effectiveness of remote stroke diagnosis and treatment, impacting the overall growth and accessibility of telestroke services on a global scale.
Segmentation: U.S. Telestroke Market
The U.S. telestroke market is segmented into eight notable segments which are based on component, facilities service, care settings, deployment type, stroke type, application, end user and distribution channel.
- On the basis of component, the U.S. telestroke market is segmented into software and services, and hardware
- On the basis of facilities service, the U.S. telestroke market is segmented into on-site, and remote
- On the basis of care settings, the U.S. telestroke market is segmented into mobile stroke units, intensive care units (ICUS), emergency departments (EDS), medical surgical units, others
- On the basis of deployment type, the U.S. telestroke market is segmented into on-premises, and cloud based
- On the basis of stroke type, the U.S. telestroke market is segmented into ischemic, haemorrhagic and transient ischemic attack (TIA)
- On the basis of application, the U.S. telestroke market is segmented into pre-hospital and hospital care, and additional applications
- On the basis of end user, the U.S. telestroke market is segmented into providers, and patients
- On the basis of distribution channel, the U.S. telestroke market is segmented into direct tenders, third party distribution, and retail sales
To know more about the study visit, https://www.databridgemarketresearch.com/zh/reports/us-telestroke-market
Recent Developments in U.S. Telestroke Market
- In November 2020, TeleSpecialists announced a significant milestone by successfully launching telestroke services for 200 hospitals, achieving this feat within seven years. Their rapid progress, doubling from 100 to 200 hospitals in just one year, solidifies their position as a leading provider of neurology services in the U.S.
- In October 2020, VeeMed launched VeeClinic, an innovative service facilitating physician-patient communication with a single click. Targeting rural areas, VeeClinic enables patients to virtually connect with specialists, aiding the company in expanding its reach and customer base, ultimately driving increased revenues
The Prominent Key Players Operating in the U.S. Telestroke Market:
- Abbott (U.S.)
- GE Healthcare (U.S.)
- VeeMed (U.S.)
- swyMe (U.S.)
- TeleSpecialists (U.S.)
- American Well (U.S.)
- InTouch Technologies, Inc. (U.S.)
- iSchemaView, Inc. (U.S.)
- The General Hospital Corporation (U.S.)
- Brigham and Women's Hospital (U.S.)
- Providence Health & Services (U.S.)
- Medical University of South Carolina (U.S.)
- Lakewood Health System (U.S.)
- Nebraska Medicine (U.S.)
- CentraCare (U.S.)
- Mayo Foundation for Medical Education and Research (MFMER) (U.S.)
- Rush Medical University Center (U.S.)
- Penn Medicine (U.S.)
- UCLA Health (U.S.)
- Medtronic (Ireland)
Above are the key players covered in the report, to know about more and exhaustive list of U.S. telestroke market companies contact, https://www.databridgemarketresearch.com/zh/contact
Research Methodology: U.S. Telestroke Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
